San Diego, CA, United States of America

Larry Kenneth Truesdale

This inventor holds 7 USPTO granted patents. Top assignees: Novo Nordisk A/s, Agouron Pharmaceuticals, Inc., Aventis Pharmaceuticals Inc.. Active years: 1995-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Larry Kenneth Truesdale. Retrieved from https://idiyas.com/inventor/larry-kenneth-truesdale

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 57.1

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 181(Granted Patents)


Location History:

  • Chester Springs, PA (US) (1995)
  • San Diego, CA (US) (2001 - 2005)

Company Filing History:


Years Active: 1995-2005

Loading Chart...
7 patents (USPTO):Explore Patents

Certainly! Here is an article about inventor Larry Kenneth Truesdale:

Title: Innovator Spotlight: Larry Kenneth Truesdale

Introduction:

Larry Kenneth Truesdale is a prolific inventor based in San Diego, California. With a strong background in pharmaceuticals, Truesdale has made significant contributions to the field of medicine through his innovative patents.

Latest Patents:

Truesdale's latest patents include Non-peptide GLP-1 agonists, which are novel compounds used in the treatment of metabolic disorders such as Type 1 and Type 2 diabetes. He has also patented Glucagon antagonists/inverse agonists, a class of compounds that counteract the effects of the glucagon hormone, making them valuable in the treatment of conditions like hyperglycemia and obesity.

Career Highlights:

Truesdale has worked with renowned companies such as Novo Nordisk A/S, where he has been instrumental in developing cutting-edge pharmaceutical solutions. His work has helped advance the field of medicine and improve treatment options for patients with various health conditions.

Collaborations:

Throughout his career, Truesdale has collaborated closely with industry experts such as Jesper F Lau and Peter Madsen. Together, they have pushed the boundaries of pharmaceutical research and development, leading to groundbreaking innovations in the field.

Conclusion:

Larry Kenneth Truesdale's dedication to innovation and his strategic collaborations have positioned him as a key figure in the pharmaceutical industry. His patents continue to impact the lives of many, offering new hope for the treatment and prevention of a range of diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…